[
  {
    "ts": null,
    "headline": "Cantor Maintains PriceTarget on BMY, Eyes Alzheimer’s Trial as Key Catalyst",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) ranks among the top stocks for an early retirement portfolio. On June 12, Cantor Fitzgerald maintained its price target of $55 and its rating of Neutral for Bristol-Myers Squibb Company (NYSE:BMY). The company’s Cobenfy’s ADEPT-2 top-line data in Alzheimer’s Disease Psychosis is anticipated in 2025, possibly as early as the second […]",
    "url": "https://finnhub.io/api/news?id=697908d20d713767484cf0a6863af0cd5fc10d4c22dfe5b76917d1e72fddf55a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750874971,
      "headline": "Cantor Maintains PriceTarget on BMY, Eyes Alzheimer’s Trial as Key Catalyst",
      "id": 135535990,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) ranks among the top stocks for an early retirement portfolio. On June 12, Cantor Fitzgerald maintained its price target of $55 and its rating of Neutral for Bristol-Myers Squibb Company (NYSE:BMY). The company’s Cobenfy’s ADEPT-2 top-line data in Alzheimer’s Disease Psychosis is anticipated in 2025, possibly as early as the second […]",
      "url": "https://finnhub.io/api/news?id=697908d20d713767484cf0a6863af0cd5fc10d4c22dfe5b76917d1e72fddf55a"
    }
  },
  {
    "ts": null,
    "headline": "Will New Drugs Enable BMY to Offset the Impact of Generic Competition?",
    "summary": "BMY depends on Reblozyl, Opdualag and Breyanzi to offset revenue hits from generics and Medicare Part D impacts.",
    "url": "https://finnhub.io/api/news?id=57eb58841c984a3c41f54f6ff2cb7c084852b5aa1ef3fff7d006015493d42d5f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750860120,
      "headline": "Will New Drugs Enable BMY to Offset the Impact of Generic Competition?",
      "id": 135526366,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "BMY depends on Reblozyl, Opdualag and Breyanzi to offset revenue hits from generics and Medicare Part D impacts.",
      "url": "https://finnhub.io/api/news?id=57eb58841c984a3c41f54f6ff2cb7c084852b5aa1ef3fff7d006015493d42d5f"
    }
  },
  {
    "ts": null,
    "headline": "3 Top Dividend Stocks to Maximize Your Retirement Income",
    "summary": "The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",
    "url": "https://finnhub.io/api/news?id=f39d731ae1d4c6ec8c12065e820c2ef6a7315d4651dbf2068d32514959a0b7dc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742389802,
      "headline": "3 Top Dividend Stocks to Maximize Your Retirement Income",
      "id": 133327071,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",
      "url": "https://finnhub.io/api/news?id=f39d731ae1d4c6ec8c12065e820c2ef6a7315d4651dbf2068d32514959a0b7dc"
    }
  }
]